Assessment and prioritization of the WHO “best buys” and other recommended interventions for the prevention and control of non-communicable diseases in Iran

Bakhtiari, Ahad; Takian, Amirhossein; Majdzadeh, Reza; Haghdoost, Ali Akbar

doi:10.1186/s12889-020-8446-x

Cited by 46 publications

(42 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this survey, the overall nutrition-related policies were the most implemented and policies related to alcohol consumption and IPA were the most neglected globally [73]. A lately conducted analysis on gaps of national targets of NCD action plan in Iran showed that among 105 actions and best-buy interventions recommended by WHO, only 12 of them were not considered in the national action plan of Iran, and only one of the best-buys Group's interventions was not included in the action plan, which was vaccination against human papillomavirus (HPV) in girls aged 9-13 years-old [74]. Achieving the targets needs persistent efforts and supports by the government and pertinent organizations [17,72].…”

Section: Discussionmentioning

confidence: 99%

Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans

Azadnajafabad

Mohammadi

Aminorroaya

et al. 2021

J Diabetes Metab Disord

View full text Add to dashboard Cite

Non-communicable Diseases (NCDs) are the leading causes of death globally, imposing a heavy burden on the healthcare systems, especially in low-and middle-income countries. Iran is a country in the Middle-East region with an aging population and changing disease risk factors, and now is facing NCDs as the major health problem of the country. Investigating NCDs' risk factors and tackling preventable ones is the main intervention to control their heavy burden. In this review, we discussed the most critical risk factors in Iran and the implemented programs and action plans to control them. A better knowledge on current status of risk factors and plans to tackle them, could help policymakers effectively rule policies and allocate resources to curb heavy burden of NCDs in Iran.

show abstract

Section: Discussionmentioning

confidence: 99%

Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans

Azadnajafabad

Mohammadi

Aminorroaya

et al. 2021

J Diabetes Metab Disord

View full text Add to dashboard Cite

show abstract

“…Selecting drugs for the formulary or drug list through MCDA could therefore present a useful approach towards making more rational, more sustainable choices in the interest of the patients and the healthcare system. Examples for using quantitative MCDA approaches [ 22 ] in listing, purchasing, tendering, or pricing decisions for commonly used medicines have been published including those which formed the base for the implementation project reported in this paper [ 9 – 12 ] and others [ 23 – 26 ]. Here we focus on the question how to implement this new, MCDA-based decision process in hospital purchasing at the example of two case studies in Indonesia and Thailand.…”

Section: Discussionmentioning

confidence: 99%

Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand

Holtorf

Kristin

Assamawakin

et al. 2021

J of Pharm Policy and Pract

View full text Add to dashboard Cite

Background A multi-criteria decision analysis (MCDA) approach has been suggested for helping purchasers in low- and middle-income countries in an evidence-based assessment of multi-source pharmaceuticals to mitigate potential adverse consequences of price-based decisions on patient access to effective medicines. Six workshops for developing MCDA-instruments for purchasing were conducted in Indonesia, Kazakhstan, Thailand, and Kuwait in 2017–2020. In Indonesia and Thailand, two pilot-initiatives aimed to implement the instruments for hospital drug purchasing decisions. Objective By analysing and comparing the experiences and progress from the MCDA-workshops and the two case-examples for hospital implementation in Indonesia and Thailand, we aim to gain insights, which will support future implementation. Methods The selection of criteria and their average weight were compared quantitatively across the MCDA-instruments developed in all four countries and settings. Implementation experiences from two case-examples were studied, which included (1) testing the instrument across a variety of drugs in seven hospitals in Thailand and (2) implementation in one specialty hospital in Indonesia. Semi-structured interviews were conducted via web-conferences with four diverse stakeholders in the pilot implementation projects in Thailand and Indonesia. The open responses were evaluated through qualitative content analysis and synthesis using grounded theory coding. Results Drivers for implementation were making ‘better’ decisions, achieving transparency and a rational selection process, reducing drug shortages, and assuring consistent quality. Challenges were seen on the technical level (definition or of criteria, scoring methods, access to data) or change-related challenges (resistance, perception of increased workload, lack of competencies or capabilities, lack of resources). The comparison of the MCDA instruments revealed high similarity, but also clear need for local adaptations in each specific case. Conclusion A set a of measures targeting challenges related to utility, methodology, data requirements, capacity building and training as well as the broader societal impact can help to overcome challenges in the implementation. Careful planning of implementation and organizational change is recommended for ensuring commitment and fit to local context and culture. Designing a collaborative change program for each application of MCDA-based purchasing will enable healthcare stakeholders to maximally benefit in terms of quality and effectiveness of care and access for patients.

show abstract

“…Because of improved health standards, the establishment of national surveillance systems, changing lifestyle and increasing urbanization rates, the pattern of diseases has been transitioning from communicable diseases towards non-communicable diseases (NCDs) in the course of last two decades [20]. Previous studies showed that air pollution and other chemical contaminations have increased the burden of non-communicable diseases (NCDs), e.g.…”

Section: Introductionmentioning

confidence: 99%

Health system plan for implementation of Paris agreement on climate change (COP 21): a qualitative study in Iran

Mousavi¹,

Ardalan²,

Takian³

et al. 2020

BMC Public Health

Self Cite

View full text Add to dashboard Cite

Background Ensuring public health is crucial in any policy debate on climate change. Paris Agreement on climate change is a global contract, through which countries have committed themselves to a public health treaty. The agreement has laid the foundation for mitigation and adaptation. This study was conducted to provide an evidence-based framework for policy-making in the health system of Iran in order to reduce the adverse effects of climate change on public health and to increase the adaptation of the health system as a result. Methods This is a qualitative study. We first used Delphi method to extract the components of Paris Agreement on climate change that were related to the functions and policymaking of health system in Iran. Twenty-three experts in health and climate change were identified purposefully and through snowball sampling as participants in Delphi. Data collection instrument was a structured questionnaire. We used SPSS software version 25 for data analysis based on the descriptive indices including the mean, the percentage of consensus above 75%, and the Kendall coordination coefficient. Results Seventy-nine components classified within nine categories were extracted. The most important examples of the implementation of Paris Agreement on climate change in the health system of Iran were: participation in the formulation of strategies for mitigation and adaptation, identifying vulnerable groups, assessing vulnerability, increasing the capacity of health services delivery during extreme events, using early warning systems, using new technologies to increase the adaptation, evaluation of interventions, financial support, increasing the number of researches, increasing the knowledge and skills of staff, and finally public awareness. Conclusions Evidence-based policy-making is pivotal to develop effective programs to control the health effects of climate change. This research provided policy translation and customization of micro and macro provisions of Paris Agreement on climate change, in line with the political context of health system in Iran. Our finding will pave the ground, we envisage, for further steps towards capacity building and enhancement of resiliency of the health system, adaptation interventions, and evaluation, identification of barriers and facilitators for adaptation and decreasing the adverse health effects caused by the climate change, in Iran and perhaps beyond.

show abstract

Assessment and prioritization of the WHO “best buys” and other recommended interventions for the prevention and control of non-communicable diseases in Iran

Cited by 46 publications

References 45 publications

Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans

Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans

Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand

Health system plan for implementation of Paris agreement on climate change (COP 21): a qualitative study in Iran

Contact Info

Product

Resources

About